Han et al. [52] reported that preoperative albumin levels below 40 g/L were significantly associated with poor prognosis in GBM patients (95% CI: 0.938–0.995, p = 0.023), with a median overall survival of 14.0 months (95% CI: 11.7–14.3). Here, ALB is linked to glioblastoma.